| Title |
Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II)
|
|---|---|
| Published in |
Trials, June 2020
|
| DOI | 10.1186/s13063-020-04380-5 |
| Pubmed ID | |
| Authors |
Qingsong Ye, Hua Wang, Xia Xia, Chenliang Zhou, Zhiming Liu, Zun-en Xia, Zhan Zhang, Yang Zhao, Jun Yehenala, Si Wang, Gangqiao Zhou, Ke Hu, Bin Wu, Chu-Tse Wu, Songling Wang, Yan He |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 33% |
| Unknown | 2 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 743 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 743 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 86 | 12% |
| Student > Master | 83 | 11% |
| Researcher | 52 | 7% |
| Student > Ph. D. Student | 45 | 6% |
| Other | 41 | 6% |
| Other | 137 | 18% |
| Unknown | 299 | 40% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 197 | 27% |
| Nursing and Health Professions | 73 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 22 | 3% |
| Biochemistry, Genetics and Molecular Biology | 19 | 3% |
| Immunology and Microbiology | 14 | 2% |
| Other | 100 | 13% |
| Unknown | 318 | 43% |